Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
1.540
-0.060 (-3.75%)
At close: Feb 21, 2025, 4:00 PM
1.610
+0.070 (4.55%)
After-hours: Feb 21, 2025, 5:50 PM EST
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $193.37 million as of February 21, 2025. Its market cap has decreased by -42.05% in one year.
Market Cap
193.37M
Enterprise Value
84.33M
1-Year Change
-42.05%
Ranking
Category
Stock Price
$1.54
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has increased from $117.04M to $193.37M, an increase of 65.22%. That is a compound annual growth rate of 13.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 193.37M | -8.33% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 780.72B |
| UnitedHealth Group | 470.30B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.39B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Intuitive Surgical | 217.02B |